Rchr
J-GLOBAL ID:200901052226735656   Update date: Jan. 09, 2025

HIYAMA EISO

ヒヤマ エイソウ | HIYAMA EISO
Affiliation and department:
Job title: Professor by Special Appointment,
Research field  (1): General surgery, pediatric surgery
Research keywords  (5): Infection ,  Cancer Biology ,  Oncologic surgery ,  Pediatric Surgery ,  Pediatric Cancer
Research theme for competitive and other funds  (57):
  • 2022 - 2025 Selection of new molecular markers for risk stratification of pediatric liver tumors based on integrated genomic analysis
  • 2019 - 2024 発がんリスク遺伝子とライフスタイルに着目した小児がん経験者の生活に関する探索研究
  • 2020 - 2023 Risk stratification of unfavorable neuroblastoma using telomere biology
  • 2019 - 2022 Next generation cancer liquid biopsy for childhood cancers using single cell analysis
  • 2016 - 2020 Study of clinical states and infrastructure development of International co-operative clinical trial for childhood liver tumors by children's cancer study group
Show all
Papers (853):
  • Salih Demir, Alina Hotes, Tanja Schmid, Stefano Cairo, Emilie Indersie, Claudio Pisano, Eiso Hiyama, Tomoro Hishiki, Christian Vokuhl, Sophie Branchereau, et al. Drug prioritization identifies panobinostat as a tailored treatment element for patients with metastatic hepatoblastoma. Journal of experimental & clinical cancer research : CR. 2024. 43. 1. 299-299
  • Isamu Saeki, Kohmei Ida, Sho Kurihara, Kenichiro Watanabe, Makiko Mori, Tomoro Hishiki, Akiko Yokoi, Junya Fujimura, Shohei Honda, Yuki Nogami, et al. Successful treatment of young childhood standard-risk hepatoblastoma with cisplatin monotherapy using a central review system. Pediatric blood & cancer. 2024. 71. 11. e31255
  • Eiso Hiyama, Tomoro Hishiki, Kenichi Yoshimura, Mark Krailo, Rudolf Maibach, Beate Haeberle, Arun Rangaswami, Dolores Lopez-Terrada, Marcio H Malogolowkin, Marc Ansari, et al. Upfront or delayed surgery in resectable hepatoblastoma: analysis from the children's hepatic tumors international collaboration database. EClinicalMedicine. 2024. 76. 102811-102811
  • Peter J K Tokuda, Yusuke Demizu, Tianyuan Wang, Nobuyoshi Fukumitsu, Takeshi Suzuki, Sho Kurihara, Eiso Hiyama, Shuhei Karakawa, Yoshiyuki Kosaka, Ryohei Sasaki, et al. First report of retroperitoneal rhabdomyosarcoma treated with space-making particle therapy for preservation of renal function. International cancer conference journal. 2024. 13. 4. 476-480
  • Hajime Uchida, Masato Shinkai, Hiroomi Okuyama, Takehisa Ueno, Mikihiro Inoue, Toshihiro Yasui, Eiso Hiyama, Sho Kurihara, Yasunaru Sakuma, Yukihiro Sanada, et al. Impact of Portal Flow on the Prognosis of Children With Congenital Portosystemic Shunt: A Multicentric Observation Study in Japan. Journal of pediatric surgery. 2024. 59. 9. 1791-1797
more...
MISC (284):
  • 兒島 正人, 藤解 諒, 栗原 將, 佐伯 勇, 檜山 英三. 摘出に難渋した縦隔奇形種の3例. 日本小児外科学会雑誌. 2024. 60. 5. 838-838
  • 栗原 將, 藤解 諒, 兒島 正人, 佐伯 勇, 檜山 英三. 両側多発肺転移,胸膜播種を伴う左第5肋骨原発ユーイング肉腫に対して集学的治療を施行した11歳女児の1例. 日本小児外科学会雑誌. 2024. 60. 5. 838-838
  • 佐伯 勇, 藤解 諒, 兒島 正人, 栗原 將, 檜山 英三. 小児がんの子ども達のためのVRゲーム作りプロジェクト. 日本小児科学会雑誌. 2024. 128. 8. 1107-1107
  • 藤解 諒, 佐伯 勇, 栗原 將, 兒島 正人, 服部 稔, 本田 有紀子, 檜山 英三, 蓮沼 直子, 粟井 和夫, 高橋 信也. Virtual Reality診察シミュレーションソフトVR OSCEによる医学生トレーニング(Medical student training using Virtual Reality examination simulation software VR OSCE). 医学教育. 2024. 55. Suppl. 274-274
  • 佐伯 勇, 藤解 諒, 服部 稔, 栗原 將, 児島 正人, 本田 有紀子, 蓮沼 直子, 高橋 信也, 粟井 和夫, 檜山 英三. Virtual Training Hospital構想 VRによるシームレスな医学教育. 医学教育. 2024. 55. Suppl. 350-350
more...
Patents (2):
Books (54):
  • 標準小児外科学
    医学書院 2017 ISBN:9784260027809
  • 小児肝腫瘍の最近の話題 : グローバル試験へ向けて
    東京医学社 2016
  • よくわかる臨床研究~小児がん~
    医薬ジャーナル社 2016 ISBN:9784753228102
  • Translational Pediatrics
    2014
  • Clinical application of molecular diagnosis -cancer, radiation effects, and human diseases-
    2010 ISBN:9788178954080
more...
Lectures and oral presentations  (90):
  • Comprehensive analysis of Hepatoblastoma
    (2018)
  • Clinical limitations, implications and ethical considerations of genetic analysis in hereditary tumors
    (第77回日本癌学会学術集会 2018)
  • Genomic landscape of hepatoblastoma
    (2018)
  • Survival and delayed effects of risk-stratified hepatoblastoma patients treated in the JPLT-2 trial
    (2018 ASCO Annual Meeting 2018)
  • Decline of ?-fetoprotein before tumor resection as a prognosis-predicting factor for hepatoblastoma
    (2018 PAPS meeting 2018)
more...
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page